ROYAL BANK OF CANADA

Bank

Position in FTRE — Fortrea Holdings Inc.

CIK 1000275 TORONTO, A6

Position in FTRE

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$736,162

-$4,055,317 QoQ

Shares Held

78,149

-71.9% QoQ

Ownership

0.083%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 99.98592432404764.ToString("F0")% Shared 0.ToString("F0")% None 0.014075675952347438.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,974,349,900 across 410 Biotechnology names. FTRE ranks #63 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,111,871	$496,494,870
2	IONS	Ionis Pharmaceuticals Inc	3,801,815	$285,478,282
3	REGN	Regeneron Pharmaceuticals, Inc.	351,171	$271,328,756
4	ALNY	Alnylam Pharmaceuticals, Inc.	791,515	$261,888,563
5	INCY	Incyte Corp	1,054,123	$99,214,053
6	INSM	INSMED Inc	523,101	$85,537,473
7	MRNA	Moderna, Inc.	999,340	$50,766,470
8	HALO	Halozyme Therapeutics, Inc.	658,290	$42,545,279

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$736,162	78,149	-71.9%	Shares	Defined	2026-05-15
2025-12-31	$4,791,479	277,767	+18.0%	Shares	Defined	2026-02-17
2025-09-30	$1,981,921	235,383	-55.2%	Shares	Defined	2025-11-14
2025-06-30	$2,596,816	525,672	+331.9%	Shares	Defined	2025-11-21
2025-03-31	$918,885	121,707	+48.9%	Shares	Defined	2025-11-21
2024-12-31	$1,524,877	81,763	-1.2%	Shares	Defined	2025-02-14
2024-09-30	$1,655,180	82,759	-31.2%	Shares	Defined	2024-11-14
2024-06-30	$2,805,885	120,218	+6.2%	Shares	Defined	2024-11-06
2024-03-31	$4,543,040	113,180	-6.1%	Shares	Defined	2024-11-05
2023-12-31	$4,206,459	120,529	-3.8%	Shares	Defined	2024-02-14
2023-09-30	$3,583,067	125,326	+476.1%	Shares	Defined	2023-11-14
2023-06-30	$739,819	21,753	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.